v3.25.1
Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Operating expenses:    
Research and development $ 39,377 $ 23,683
General and administrative 12,147 10,240
Total operating expenses 51,524 33,923
Loss from operations (51,524) (33,923)
Other income (expense):    
Interest income, net 3,602 4,748
Other (expense) income, net (15) 469
Interest expense (4) (391)
Total other income, net 3,583 4,826
Loss before income taxes (47,941) (29,097)
Income tax benefit 30 32
Net loss $ (47,911) $ (29,065)
Basic net loss per common share outstanding $ (0.47) $ (0.29)
Diluted net loss per common share outstanding $ (0.47) $ (0.29)
Weighted average common shares used in net loss per share attributable to common stockholders, basic 101,971,873 99,033,373
Weighted average common shares used in net loss per share attributable to common stockholders, diluted 101,971,873 99,033,373
Net Income (Loss) $ (47,911) $ (29,065)
Other comprehensive income:    
Net unrealized gains on available-for-sale marketable securities 90 93
Comprehensive loss $ (47,821) $ (28,972)